Home/Filings/4/0000950170-24-112898
4//SEC Filing

SMITH IAN F 4

Accession 0000950170-24-112898

CIK 0001707502other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:05 PM ET

Size

7.3 KB

Accession

0000950170-24-112898

Insider Transaction Report

Form 4
Period: 2024-10-03
SMITH IAN F
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-10-03+3,255109,717 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-10-033,2553,255 total
    Common Stock (3,255 underlying)
Footnotes (2)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.

Documents

1 file

Issuer

Solid Biosciences Inc.

CIK 0001707502

Entity typeother

Related Parties

1
  • filerCIK 0001197032

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:05 PM ET
Size
7.3 KB